Chemoinformaics analysis of HARMIC-ACID-METHYL-METHYLESTER
| Molecular Weight | 618.855 | nRot | 5 |
| Heavy Atom Molecular Weight | 564.423 | nRig | 35 |
| Exact Molecular Weight | 618.392 | nRing | 6 |
| Solubility: LogS | -4.902 | nHRing | 0 |
| Solubility: LogP | 7.379 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 39 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 105.949 |
| nHD | 1 | BPOL | 60.2492 |
| QED | 0.262 |
| Synth | 4.768 |
| Natural Product Likeliness | 2.619 |
| NR-PPAR-gamma | 0.977 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.052 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -5.106 |
| MDCK | 0.0000165 |
| BBB | 0.006 |
| PPB | 1.00757 |
| VDSS | 0.792 |
| FU | 0.0279658 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.15 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.881 |
| CYP2c9-inh | 0.122 |
| CYP2c9-sub | 0.859 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.127 |
| CYP3a4-inh | 0.214 |
| CYP3a4-sub | 0.337 |
| CL | 1.86 |
| T12 | 0.01 |
| hERG | 0.002 |
| Ames | 0.018 |
| ROA | 0.056 |
| SkinSen | 0.009 |
| Carcinogencity | 0.032 |
| EI | 0.489 |
| Respiratory | 0.907 |
| NR-Aromatase | 0.757 |
| Antiviral | Yes |
| Prediction | 0.81402 |